Tuesday, June 7 | 2:30 PM - 4:00 PM
Upon completion of this activity, the participant will be able to:
1. Discuss the value of multimodality imaging in coronary artery disease.
2. Define the costs associated with potentially improved diagnostic accuracy with multimodality imaging.
3. Review clinically relevant information beyond perfusion that can be obtained by imaging.
Mark I. Travin, MD, Montefiore Medical Center, Bronx, N.Y.;
Daniel S. Berman, MD, Cedars-Sinai Medical Center in Los Angeles;
Ahmed A. Tawakol, MD, Massachusetts General Hospital; and
Louise Thomson, MBChB, Cedars-Sinai Medical Center in Los Angeles.